D
Deborah F. Mason
Researcher at Christchurch Hospital
Publications - 28
Citations - 1209
Deborah F. Mason is an academic researcher from Christchurch Hospital. The author has contributed to research in topics: Population & Neuromyelitis optica. The author has an hindex of 12, co-authored 28 publications receiving 988 citations. Previous affiliations of Deborah F. Mason include Auckland City Hospital.
Papers
More filters
Journal ArticleDOI
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
Melanie Bahlo,David R. Booth,Simon A. Broadley,Matthew A. Brown,Matthew A. Brown,Simon J. Foote,Lyn R. Griffiths,Trevor J. Kilpatrick,Trevor J. Kilpatrick,Jeanette Lechner-Scott,Pablo Moscato,Victoria M. Perreau,Justin P. Rubio,Rodney J. Scott,Rodney J. Scott,Jim Stankovich,Graeme J. Stewart,Bruce V. Taylor,James S. Wiley,Glynnis Clarke,Mathew B Cox,Peter A. Csurhes,Patrick Danoy,Karen E. Drysdale,Judith Field,Judith M. Greer,Preethi Guru,Johanna Hadler,Brendan J. McMorran,Cathy J Jensen,Laura J. Johnson,Ruth McCallum,Marilyn E. Merriman,Tony R. Merriman,Karen Pryce,Lotfi Tajouri,Ella J Wilkins,Brian L. Browning,Sharon R. Browning,D. I. Perera,Simon Broadley,Helmut Butzkueven,Helmut Butzkueven,William M. Carroll,Caron Chapman,Allan G. Kermode,Mark Marriott,Deborah F. Mason,Robert Heard,Michael P. Pender,Michael P. Pender,Mark Slee,Niall Tubridy,Ernest Willoughby +53 more
TL;DR: To identify multiple sclerosis (MS) susceptibility loci, a genome-wide association study in 1,618 cases and used shared data for 3,413 controls and observed a statistical interaction between SNPs in EVI5-RPL5 and HLA-DR15.
Journal ArticleDOI
Incidence and prevalence of NMOSD in Australia and New Zealand
Wajih Bukhari,Kerri Prain,Patrick Waters,Mark Woodhall,Cullen O'Gorman,Laura Clarke,Roger Silvestrini,Christine Bundell,David Abernethy,Sandeep Bhuta,Stefan Blum,Mike Boggild,Karyn Boundy,Bruce J. Brew,Matthew A. Brown,Wallace J Brownlee,Helmut Butzkueven,William M. Carroll,Celia Chen,Alan Coulthard,Alan Coulthard,Russell C. Dale,Chandi Das,Keith Dear,Marzena J. Fabis-Pedrini,David A. Fulcher,David Gillis,Simon Hawke,Robert Heard,Andrew P.D. Henderson,Saman Heshmat,Suzanne Hodgkinson,Suzanne Hodgkinson,Sofia Jimenez-Sanchez,Trevor Killpatrick,John King,Christopher Kneebone,Andrew J. Kornberg,Jeannette Lechner-Scott,Ming-Wei Lin,Christpher Lynch,Richard A L Macdonell,Deborah F. Mason,Pamela A. McCombe,Michael P. Pender,Jennifer Pereira,John D. Pollard,Stephen W. Reddel,Cameron Shaw,Judith M. Spies,Jim Stankovich,Ian Sutton,Steve Vucic,Michael Walsh,Richard C. W. Wong,Eppie M. Yiu,Michael Barnett,Allan G. Kermode,Mark Marriott,John Parratt,Mark Slee,Bruce V. Taylor,Ernest Willoughby,Robert Wilson,Angela Vincent,Simon Broadley +65 more
TL;DR: A clinic-based survey of neuromyelitis optica spectrum disorders in Australia and New Zealand found NMOSD to be more common in the population with Asian ancestry and incidence and prevalence are comparable with figures from other populations of largely European ancestry.
Journal ArticleDOI
MS prevalence in New Zealand, an ethnically and latitudinally diverse country.
Bruce V. Taylor,John F. Pearson,Glynnis Clarke,Deborah F. Mason,David Abernethy,Ernie Willoughby,Clive E. Sabel +6 more
TL;DR: This study confirms the presence of a robust latitudinal gradient of MS prevalence in New Zealand, largely driven by European females with the RRMS/SPMS phenotype, and indicates that the environmental factors that underlie this gradient act differentially by gender, ethnicity and MS phenotype.
Journal ArticleDOI
Neurological and systemic complications of tuberculous meningitis and its treatment at Auckland City Hospital, New Zealand.
TL;DR: The most common complications in the 81 long-term survivors were cognitive impairment and epilepsy, and Neurological and systemic complications of tuberculous meningitis were common and were important causes of mortality and long- term morbidity.
Journal ArticleDOI
Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
Bruce V. Taylor,Andrew J. Palmer,Steve Simpson,Robyn M. Lucas,Rex D. Simmons,Deborah F. Mason,John F. Pearson,Glynnis Clarke,Clive E. Sabel,Ernie Willoughby,Anne Richardson,David Abernethy +11 more
TL;DR: The demographic and disease characteristics of participants in the Australian Multiple Sclerosis Longitudinal Study are compared with two well-characterised MS prevalence studies with near-complete ascertainment of MS in their study regions to show the AMSLS data can be generalised to the whole Australasian MS population.